PME: Beth Israel Lahey $90m Contract & Head of Business Operations/IR Resignation

Research evidence excerpt

PME: Beth Israel Lahey $90m Contract & Head of Business Operations/IR Resignation

EQUITY RESEARCH QUICK TAKE

Royal Bank of Canada, Sydney Branch

Jackson Lee (Analyst)

May 17, 2026

Pro Medicus Limited

Beth Israel Lahey $90m Contract & Head of Business Operations/IR Resignation

ASX: PME | AUD 122.11 | Sector Perform | Price Target AUD 190.00

Sentiment: Positive

RBC View. Scoring another win in the academic space with a 7-year $90m win with Beth Israel Lahey for full stack announced

(viewer, workflow, archive). Incrementally positive and implies ~$12.8m annualised revenue with go-live targeted for 1Q27,

representing ~3.6% of RBCe FY27 ~$350m. Separately, the announcement of the resignation of Clayton Hatch, Head of Business

Operations and IR, and previously long-serving group CFO - No official reason for departure, however we don't expect anything

materially negative, with Hatch remaining in the role until 14th August 2026. With Hatch having been with PME for nearly 18

years, as well as being instrumental in executing the company's global expansion and growth phases over the past two decades,

we believe the loss of a seasoned executive may weigh on sentiment this morning.

Deal Details:

• A$90m, 7-year contract with Beth Israel Lahey Health, a healthcare system with 14 hospitals serving Eastern Massachusetts/

Southern New Hampshire with over 4,700 physicians and 39,000 employees.

• Rollout commences immediately through cloud.

• Targeted go-live of 1Q CY27.

• Implies incremental ~$12.8m annualised revenue.

• Transaction based with potential upside to minimum contract value on volumes.

All values in AUD unless otherwise noted. Priced as of prior trading day's market close, EST (unless otherwise noted).

Disseminated: May 17, 2026 20:19EDT; Produced: May 17, 2026 20:19EDT